Cooper Barghols

Life Sciences

• BPOC-backed MPE, a provider of electromechanical and robotic-assisted surgical systems for the medical device market, in its sale to Graham Partners.
• Catalyst Pharmaceuticals (Nasdaq: CPRX), a commercial-stage biopharmaceutical company, in its pending $4.1 billion sale to Angelini Pharma.
• Danaher Corp. (NYSE: DHR) in its pending $9.9 billion acquisition of Masimo Corp. (Nasdaq: MASI), a provider of specialty diagnostics including pulse oximetry and other patient monitoring solutions.
• Eli Lilly (NYSE: LLY) in its pending $7.8 billion acquisition of Centessa Pharmaceuticals (Nasdaq: CNTA), a provider of medicines for the treatment of excessive daytime sleepiness and other neurological conditions.
• KalVista Pharmaceuticals (Nasdaq: KALV), a provider of oral therapies for individuals affected by rare diseases, in its pending $1.9 billion sale to Chiesi.
• Kimberly-Clark Corp. (Nasdaq: KMB) in its pending $48.7 billion acquisition of Kenvue (NYSE: KVUE), a global consumer health company.
• Owens & Minor (NYSE: OMI) in its proposed $1.4 billion acquisition of Rotech Healthcare Holdings.
• Owens & Minor (NYSE: OMI) in the $375 million sale of its Products & Healthcare Services segment, a provider of medical and surgical supplies, to Platinum Equity.
• Transcend Therapeutics, a clinical stage biotechnology company developing treatments for neuropsychiatric diseases, in its pending $1.225 billion sale to Otsuka Pharmaceutical.

Technology

• Altaris in its $540 million acquisition of Sharecare (Nasdaq: SHCR), a provider of a digital healthcare platform.
• Bain Capital in its acquisition of HealthEdge, a provider of healthcare technology solutions, from Blackstone.
• Bain Capital-backed HealthEdge in its merger with UST HealthProof, a provider of business transformation and business processing as a service (BPaaS) solutions for health plans.
• Berkshire Partners in its acquisition of Medalogix, a provider of clinical support solutions.
• Parthenon Capital in its investment in Medical Review Institute of America (MRIoA), a provider of outsourced utilization management and clinical review solutions to payers.

Healthcare

• Accel KKR in its acquisition of ECRI’s Spend Management and Recall Management solutions business as an independent company.
• General Catalyst and Health Assurance Transformation, LLC (HATCo) on the proposed combination of Summa Health with HATCo.
• GTCR, alongside Recognize, in the $632.4 million acquisition of TRANZACT from WTW (Nasdaq: WTW).

Restructuring

• Dental Care Alliance, a portfolio company of Harvest Partners, Mubadala Investment Company and PSP Investments, in connection with its entry into a restructuring support agreement.
• Invitae Corporation and certain of its affiliates in their prearranged Chapter 11 cases in the U.S. Bankruptcy Court for the District of New Jersey. Invitae is headquartered in San Francisco, California and is a leader in the genetic testing field. Prior to commencing Chapter 11, Invitae secured support to implement a go-forward sale process by signing a transaction support agreement with a significant majority of its secured noteholders. Invitae is a publicly traded company and listed approximately $1.5 billion in funded debt obligations as of the petition date.
• Vyaire Medical, Inc. and its 27 debtor affiliates in the completion of the sales of substantially all assets, including medical device products, related to its two business units under Section 363 of the U.S. Bankruptcy Code and confirmation of its Chapter 11 plan.